Aleksandra Rachitskaya, MD, FASRS

home / authors / aleksandra-rachitskaya-md-fasrs

Articles

Achieving Superior Treatment Durability and Outcomes In Neovascular AMD and DME

Achieving Superior Treatment Durability and Outcomes In Neovascular AMD and DME

Paul Hahn, MD, PhD, FASRS;Michael Cohen, MD, FAAO;Aleksandra Rachitskaya, MD, FASRS
November 10th 2023

Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.

Read More

Achieving Superior Treatment Durability and Outcomes in Neovascular AMD and DME

Achieving Superior Treatment Durability and Outcomes in Neovascular AMD and DME

Paul Hahn, MD, PhD, FASRS;Michael Cohen, MD, FAAO;Aleksandra Rachitskaya, MD, FASRS
October 31st 2023

Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
HCPLive Cardiology Month in Review: April 2024
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children
Published: November 19th 2024 | Updated: November 21st 2024
Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children
Widespread "Yellow Bumps"
Published: October 9th 2014 | Updated: November 21st 2024
Widespread "Yellow Bumps"
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD
Published: November 18th 2024 | Updated: November 21st 2024
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Published: November 16th 2024 | Updated: November 21st 2024
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
© 2024 MJH Life Sciences

All rights reserved.